Mpl proto-oncogene, thrombopoietin receptor
| GO Term | Evidence Code | PMID |
|---|---|---|
| neutrophil homeostasis |
|
|
| neutrophil homeostasis |
|
|
| positive regulation of gene expression |
|
|
| platelet formation |
|
|
| platelet formation |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| Golgi apparatus |
|
|
| Golgi apparatus |
|
|
| Golgi apparatus |
|
|
| plasma membrane |
|
|
| plasma membrane |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytokine receptor activity |
|
|
| thrombopoietin receptor activity |
|
|
| thrombopoietin receptor activity |
|
|
| thrombopoietin receptor activity |
|
|
| thrombopoietin receptor activity |
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0090118 | congenital amegakaryocytic thrombocytopenia |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026